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Summary Record linkage was carried out between the national Registry of AIDS and 13 Cancer Registries (CRs) covering, in 1991. about
15Yo of the Italian population. Observed and expected numbers of cancers and standardized incidence ratios (SIRs) were assessed in 6067
persons with AIDS. for a total of 25 759 person-years. Significantly increased SIRs were found for Hodgkin's disease [8.9. 950o confidence
interval (Cl) 4.4-16.0], in which seven of 11 cases were of mixed cellularity type: invasive carcinoma of the cervix uten (15.5: 950° Cl
4.0-40.1): and non-melanomatous skin cancer (3.0. 950°o Cl 1.3-5.9). in which five of eight cases were basal cell carcinoma. An excess was
also seen for brain tumours, but this may be partly due to misdiagnosis of brain non-Hodgkin's lymphoma or other brain diseases occurring
near the time of the AIDS diagnosis. The risk for all cancer types. after exclusion of Kaposi's sarcoma (KS) and non-Hodgkin's lymphoma
(NHL). was approximately twice the general population risk. An increased SIR for Hodgkin's disease in persons with AIDS is thus confirmed,
though it is many times smaller than that for NHL. An association with invasive carcinoma of the cervix is also shown at a population level. The
excess of non-melanomatous skin cancer seems to be lower than in transplant recipients.
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Human immunodeficiency Xirus HIV -infected individuals
exhibit a greatlv increased risk of Kaposi's sarcoma (KS) (more
than 1000 fold) and non-Hodgkin's lI-mphoma (NHL) (about 100-
fold) (LARC. 1996). Increases haxe also been reported for other
cancer sites or trpes. such as squamous carcinomas of the anus.
cerxix uteri. skin and conjunctiva. and Hodzkin's disease (IARC.
1996). As most of these malignancies are associated wxith viruses.
cancer excesses are likelx to result from the combined effects of
infectixe agents other than HIV [e.g. Epstein-Barr virus )EBV)
and human papillomaxvirus (HPV)] and the immune suppression
and dvsregulation associated wxith HIV infection (IARC. 1995.
1996: Kinlen. 1996). Excesses of neoplasms. such lung cancer.
testicular cancer and hepatocellular carcinoma. have been less
consistently reported (LARC. 1996). Uncertaintv stems not onlv
from the relatixelv small numbers of each cancer observed and
from possible surneillance bias. but also from the difficulty in
disentan-lino the role of HIV from that ofbehavioural risk factors
(e.g. smoking. sexual promiscuitx). which are common in some
HIV exposure categories (IARC. 1995. 1996).
Italv offers an important research opportunity as AIDS has
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spread faster and w-omen are proportionally more common among
AIDS patients than in most other dex eloped countries (Dal 'Maso
et al. 1995). Furthermore. the whole population is covered bv an
AIDS sun-eillance programme and a substantial proportion of the
population by cancer registration sxstems. thus making record
linkage studies possible (Cote et al. 1995: Franceschi et al. 1998).
Here. w-e report the first results of such a study w-ith respect to
cancers other than KS and NHL.
MATERIALS AND METHODS
The design and methods of our record linkage studv have alreadv
been described )Franceschi et al. 1998). Brieflx. notifications of
persons Vith AIDS from all over Italy to the Registrv of AIDS
(RAIDS) (located at the Centro Operativo AIDS. Istituto
Superiore di Sanita. Rome. Italy) started in 1982 on a voluntan-
basis and became mandatorv in November 1986. Bv the end of
MIarch 1996. a total of 33 304 AIDS cases had been notified. A
linkaee of RAIDS data and death certificates for 1992 suggested
that underreporting of AIDS cases in Italx v-as less than 10%. a
lexel comparable to the situation in other developed countries
(Conti et al. 1997).
Thirteen Cancer Registries (CRs( w-ere active in Ital in the
earlx 1990s (for a population of 8 137 900 in 1991. 15% of the
Italian population): the municipalities of Turin and Genoa. the
provinces of Varese. Trieste. Parma. Modena. Ferrara. Macerata.
-Stud! group listed in Appendix
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Table 1 Observed (Obs) and expected (Exp) number of cancer and standardized incidence ratio (SIR) in persons with AIDS, by interval between cancer and
AIDS diagnosis. Italy 1976-94
Cancer site or type Before AIDS After AIDS
5-3 years .<2 years .2 years Total
Obs SIR Obs SIR Obs SIR Obs Exp SIR 95% CI
No. of AIDS cases 5742 4800 2928 6067
(person-years) (14 997) (7801) (2961) (25 759)
Stomach 1 1.4 1 2.3 1 6.9 3 1.3 2.3 0.4-6.9
Rectum 0 0.0 1 4.0 1 11.7 2 0.8 2.7 0.3-9.8
Lung 0 0.0 3 2.8 4 11.2a 7 3.2 2.2 0.9-4.5
Clinical diagnoses excluded 0 0.0 1 0.9 2 5.6 3 3.2 0.9 0.2-2.8
Melanoma 0 0.0 2 5.5 0 0.0 2 1.1 1.8 0.2-6.7
Skin. non melanoma 3 2.1 4 4.4a 1 2.9 8 2.7 3.0 1.3-5.9
Female breast 1 1.4 1 2.5 0 0.0 2 1.2 1.6 0.2-5.9
Cervix uten 1 6.9 3 37.8a 0 0.0 4 0.3 15.5 4.0-40.1
Testis 0 0.0 3 6.5a 0 0.0 3 1.5 2.0 0.4-6.1
Brain 0 0.0 3 1 O.0a 4 34.0a 7 0.9 7.5 3.0-15.5
Clinical diagnoses excluded 0 0.0 1 3.3 0 0.0 1 0.9 1.1 0.0-6.1
Hodgkin's disease 3 4.2 5 13.2a 3 20.4a 11 1.2 8.9 4.4-16.0
Leukaemias 0 0.0 1 3.5 1 9.5 2 0.9 2.2 0.2-8.1
All sites-- 14 1.0 30 3.7a 18 6.1a 62 24.7 2.5 (1.9-3.2)
Clinical diagnoses exduded 13 1.0 25 3.1a 10 3.4a 48 24.7 1.9 (1.4-2.6)
a95% Cl does not include unity. :AJI sites except Kaposi's sarcoma and non-Hodgkin's lymphomas. -Indudes one each of lip (clinical diagnosis); nasopharynx;
colon (clinical diagnosis); larynx; thymus: ovary (clinical diagnosis); kidney; thyroid gland; adrenal gland: other endocrine glands (clinical diagnosis); and multiple
myeloma. Cl. confidence interval.
Florence. Latina and Ragusa. and the Regions of Romagna and
Veneto (Muir et al. 1987: Parkin et al. 1992. 1997: Franceschi et al.
1998). CRs sary greatly in size (covering about 260 000 to nearlv
1.5 million people). and in number of registration years. Only
Varese. Parma. Latina and Ragusa date back to the early 1980s
(Muir et al. 1987: Franceschi et al. 1998). Routine indicators of
data completeness and quality in Italian CRs are satisfactory (Muir
et al. 1987: Parkin et al. 1992. 1997).
We deseloped software that generates matched files from
RAIDS and CRs. Records sere linked by last and first name and
date of birth. The name-date algorithm required (a) that the
records were identical for at least one critical field and (b) that the
other two critical fields. ifnot identical. differed only in prescribed
ssavs (Franceschi et al. 1998.) As the system subsequently
remosed all personal identifiers. the staff of each type of registry
did not know which persons had been linked.
The present comparison of RAIDS and CR files w-as restricted
to persons who (1) sere aged 15-69 years at the time of the diag-
nosis of AIDS. (2) reported a legal residence in areas covered by
CRs and (3) were diagnosed with cancer in periods deemed
complete at both registries (i.e. in most instances up to the end of
1992: Franceschi et al. 1998).
Cancers at CRs s-ere identified according to the International
Classification of Disease. 9th revision (codes 140-208) (WHO.
1977). Because of specific problems of diagnostic qualitv in
persons with AIDS. cancers wvere further subdivided according to
whether histological. haematologyical or cytological confirmnation
v as asailable ordiagnosis s as made on othergrounds (i.e. clinical
diagnosis). KS (classified by means of the International
Classification of Diseases for Oncology morphology code 9140/3.
irrespective of anatomical site) and NIHL have been AIDS-
defining illnesses since 1985 and s%ere not considered in detail in
the present report. Cer ical cancer. which has been part of AIDS
case definition onlv since 1993 (i.e. after the present study period).
was included. In situ carcinomas ofthe cervix swere excluded.
Person-years at risk were computed from 5 years before AIDS
diagnosis (in order to exclude cancer diagnoses that may have
occurred before HIV infection) to date of death or 2 years after
AIDS diagnosis (to reduce inaccuracies from losses to follow--up).
This interval was left or right censored if no complete CR data
were asvailable in the corresponding years. Expected numbers of
different cancer sites or types for periods from 5 to 2 years prior to
AIDS and for the 2 years on either side of the AIDS diaenosis
were computed (Muir et al. 1987: Parkin et al. 1992. 1997).
Observed numbers ofcancer in persons w-ith AIDS s ere compared
with expected numbers by means of standardized incidence ratios
(SIRs). Corresponding 95% confidence intervals (CIs) were
computed using the Poisson distribution (Breslow and Day. 1987).
RESULTS
Among 6067 persons with AIDS (4801 men and 1266 wsomen) and
over 25 759 person-years (89%c ofswhich were prior to the diagnosis
of AIDS). 62 cancers other than KS and N-IL were identified (SIR
2.5. 95% CI 1.9-3.2) (Table 1). Forty-four cancers had occurred
before AIDS diagnosis. The proportions of cancers diagnosed only
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Table 2 Observed (Obs) number of non-melanomatous skin cancer. cancer of the cervix uten and Hodgkin's disease and standardized incidence ratio (SIR) in
persons with AIDS by gender. age group and HIV exposure category. Italy. 1976-94
Non-
melanomatous Cancer of the cervix Hodgkin's
sin cancer uteri disease
Obs SIR Obs SIR Obs SIR
(95% Cl) (95% Cl) (95% Cl)
Gender
Men 7 3.0 - - 9 9.3
(1.2-6 2) (4.2-17.7)
Women 1 2.8 4 15.5 2 7.7
(0 0-16.2) (4.0-40.1) (0.7-281)
Age group
15-34 0 0 3 24.8 9 10.2
_ (4.7-73 5) (4.6-19.5)
35-69 8 3.7 1 7.3 2 5.7
(1.6-7.4) (0.0-41 9) (0.5-21.0)
HIV exposure category
Intravenous drug users 1 1.2 3 19.0 7 8.1
(0.0-7.2) (3 6-56.3) (3.2-16.9)
Other 7 3.7 1 10.0 4 10.8
(1.5-7 7) (0.0-57.3) (2.8-27.9)
Cl = confidence interval.
clinicallx in persons
'ith AIDS was higher than in the general popu-
lation from the same CRs. particularly at some sites (e.g. brain and
lung). and in the vears followingt AIDS diagnosis. Restricting the
analvsis to cancers with histoloaical. cytological or haematological
confirmation. the SIR was 1.9 (95%c CI 1.4-2.6).
Significantlv elexated SIRs were seen for non-melanomatous
skin cancer (3.0. 95%ce CI 1.3-5.9). cancer ofthe cervix uteri (15.5.
95%c CI 4.0-40.1) and Hodakin's disease (HD) (8.9. 95%c CI
4.4-16.0). The skin cancers included three squamous cell carci-
nomas and fix-e basal cell carcinomas. All cancers of the cervix
w-ere squamous cell carcinomas. Sexen ofthe 11 cases of HD w-ere
of the mixed cellularitv txype. The other cases of HD show-ed
l1xmphocx%tic predominance (n = 2). lymphocvtic depletion (n = 1)
or wxere of unspecified tvpe (n = 1). The highest SIRs were found
in the 2 xears before AIDS for cancer of the skin and cerxix. but
after AIDS for HD.
Sexen brain tumours wxere found (SIR 7.5. 95%e CI 3.0-15.5).
but only one was histologically confirmed (SIR 1.11. For the
others. the date of diaanosis coincided with or was close to the
diagnosis ofAIDS. Concurrent AIDS-defining illnesses at RAIDS
included brain NHL (i = 2) and HIV encephalopathv (n = 1).
Potential diagnostic problems also emerged for cancer of the lung
(SIR 2.2. 95%7c CI 0.9-4.5). Only three ofsexven cancers were histo-
logically confirmed (one each ofsquamous cell carcinoma. adeno-
carcinoma and giant cell carcinoma) (SIR 0.9). For the others.
cancerdiagnosis was close in time to the AIDS diagnosis. and lung
lesions of infectious origin. such as Pneu,mocvstis carinii and lun2
candidiasis. w-ere reported at RAIDS (Table 1).
The three cancer sites or types w-hich showed a significant
excess in persons with AIDS were re-examined in separate strata
ofgender. agre at AIDS and HIV exposure categorx (Table 2 ). SIRs
xwere similar in men and x-omen. where applicable. The age distri-
bution at cancer diacgnosis xvaried: the aae range w-as 39-66 years
for non-melanomatous skin cancer (median 59). 2-34 years for
cancer of the cerxix uteri (median 28) and 24-38 y ears for HD
(median 28). SIRs were somewxhat more mark-ed in the 15-34
vears age group for cancer ofthe cerxix and HD. and among intra-
xenous drug users (IDUs(for cancer ofthe cerxix (Table 2 ).
Finallv. in the same dataset. 111 cases of NHL (SIR 58.6. 95%'g7
CI 48.2-70.6) and 151 of KS (SIR > 1300) were identified.
DISCUSSION
Three cancer sites ortypes. otherthan KS and NHL. hax-e been found
in our study to be significantly increased in persons wxith AIDS: HD.
cancer ofthe cerv-ix uteri and non-melanomatous skin cancer.
HD showed a ninefold excess. xhich xxas consistent in strata of
gender. are and HIV exposure category. The highest SIRs xere
found in the years around AIDS diagnosis. suggesting that they
were proportional to the degree of immunosuppression. as for
NHL (IARC. 1996). Similar results haxe emerged in twxo other
linkaae studies from San Francisco. USA (SIR 8.8. 95% CI
5.0-14.3) (Revnolds et al. 1993). and New South Wales. Australia
(SIR 8.5. 95%e CI 4.1-16) (Grulich et al. 1997). In addition. these
findinas add to several reports ofHD excesses in HIV-seropositix e
cohorts (Lvter et al. 1995: Serraino et al. 1997). to the twxofold
increase in HD in nexer married men aaed 25-54 in San Francisco
betxeen the periods 1973-79 and 1988-90 (Rabkin and Yellin.
1994) and in HIV-seropositixe black patients in South Africa (non-
si2nificant difference) (Sitas et al. 1997). Thus. an association
betxeen HD and HIV infection seems to be wxell established.
although with a SIR much lowxer than that for NHL (IARC. 1996).
This is in contrast to the lack of an increase in HD in any of the
studies of transplant recipients (Kinlen. 1996). B-cell hyperplasia
is not a feature of iatrogenic immunosuppression as it is in HIV
infection. xxhich may explain wxhy certain types of lymphomas.
namely HD and Burkitt's ly-mphoma. are relatixely frequent in
AIDS patients but not in transplant recipients (IARC. 1996).
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Misdia2nosis ofNHL as HD cannot be totallv ruled out because
the classification oflymphatic neoplasms in AIDS patients is diffi-
cult (Gaidano and Carbone. 1995). Histological confirmation was.
however, present and checked for all cases of HD in our studv. In
fact. as in previous reports (Andrieu et al. 1993: Serraino et al.
1993) the nodular sclerosis type (the commonest type in this age
aroup in the general population: Serraino et al. 1993) was not
found: instead. tumours of mixed cellularity type predominated.
Besides being more aggressive and involving bone marrow more
frequently. HD in HIV-infected patients seems to be associated
with Epstein-Barr -irus more commonly than in the gieneral
population (Tirelli et al. 1995).
Cancer of the cervix uteri was found in four A-omen (16 times
the expected number). All cancers of the cervix had occurred
several (i.e. 5. 8. 9 and 51 ) months before the diagnosis of AIDS.
Among previous record linkage studies. only Reynolds et al
(1993) reported on malignancies (only 0.3%'7 ofthe total) in women
with AIDS. SIR w-as 6.5 for in situ carcinoma of the cervix. based
on two cases (Reynolds et al. 1993).
HIV-associated immunosuppression has been consistentlv
shown to increase a person's risk of diseases caused by human
papillomavirus (HPV.) including squamous intra-epithelial lesions
and in situ carcinoma ofthe cervix. However, confounding caused
by sexual promiscuity has been difficult to exclude (IARC. 1995.
1996). Besides bein2 more prevalent in HIV-seropositive women
in cross-sectional studies (IARC. 1996). HPV cervical infections
w-ere shoun in a prospectiv-e investigation (Sun et al. 1997) to be
about seven times more likely to persist in seropositive than in
HIV-serone2atiVe women. Persistence was inversely related to
CD4- counts (Sun et al. 1997). In a case-control study of black
cancer patients in South Africa. HIV seropositivity was slightly
lower (3.9%7/) among, 180 w-omen with cervical cancer than in 218
women (8.3%7) with a variety of cancers not suspected of having
an infectious cause (Sitas et al. 1997). Furthermore. the AIDS
epidemic did not seem to affect cervical cancer incidence durinns
the late 1980s in the USA (Rabkin et al. 1993) or in Africa (Rabkin
and Blattner. 1991: Sitas et al. 1997). but various factors. includintt
downward incidence trends in the aeneral population. relatively
late spread of AIDS amons2 women and cervical screeninga prac-
tices (i.e. the frequent removal of in situ lesions). may account for
the difficultv of establishina an association between HIV and
invasive cervical cancer. However. the present elevated SIR for
cervical cancer needs further confirmation.
For non-melanomatous skin cancer. a moderate excess wAas seen
in persons with AIDS. Misclassification with KS seems unlikelv.
as all the non-melanomatous skin cancers in persons with AIDS
were histologicallv confirmed. Of more concern is the complete-
ness of CR data on skin cancer in the general population. Tu-o
melanomas and one cancer of the lip also exceeded the expected
numbers. although the increases were not si,nificant. No data on
skin cancer from other linkane studies are available. but Grulich et
al (1997) reported a fourfold increased risk of cancer of the lip. In
addition. results from HIV-seropositive cohorts are scanty and
inconclusive (Ragni et al. 1993: Lvter et al. 1995). It is clear.
however. that skin cancer in our study affected more older individ-
uals than w-ere affected by HD and cancer of the cervix.
Furthermore. the excess in persons with AIDS w-as much lower
than in transplant recipients in the United Kin2dom-Australasian
Collaborative Study (9.1-fold increased risk: Kinlen et al. 1983)
and those from N'ordic countries (over 20-fold: Birkceland et al.
1995)>. especially for squamous cell carcinomas.
The findings for cancer of the lung and brain are of interest. but
masses of non-neoplastic origin or attributable to NHL are
common at AIDS diagnosis. and these mav be misdia2nosed as
cancers of the lung or brain. particularly as histological confirma-
tion is often lacking. Thus. there is a need for the quality ofcancer
reristration in AIDS patients to be improved.
No si1nificantlv elevated SIRs were found forother cancer sites or
ty-pes. although several SIRs were above unity and confidence inter-
vals were broad because of the small study size. At variance with a
studv from the USA (Melbye et al. 1994). no excess of anal cancer
w-as identified. This may be because in Italv onl1 a minorit- ofAIDS
patients are recorded as homosexual or bisexual (18% ofmale cases)
(Dal Maso et al. 1995). Furthermore. levels of promiscuity in this
group seem lower than in the USA (Franceschi et al. 1989).
Strengths and weaknesses of the studv in which CRs and AIDS
registries are linked have been reviewed elsewhere (Melbve et al.
1994: Cote et al. 1995: Bigcar et al. 1996: Franceschi et al. 1998).
We could have underestimated the number of persons with AIDS
and cancer through failures of reporting to either registry or
through missed linkages. although the procedures we used hav-e
been v-alidated (Franceschi et al. 1998). The problem of mi2ration
out of CR areas should be less severe in Italv than elsewhere. as
population mobility is comparativel1 low Franceschi et al. 1998).
Finallv. SIRs of some tumours (e.g. HD) after the diagnosis of
AIDS may have been increased by more thorough investigation of
accompanying illnesses. However. as cancer excesses were found
before AIDS diagnosis. thev should not be totally attributable to
the intensive evaluation of persons at the time of AIDS discover-
(Biggaretal. 1996).
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APPENDIX: CANCER AND AIDS REGISTRY
LINKAGE STUDY
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